Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Non-Current Assets (2020 - 2025)

IceCure Medical (ICCM) has disclosed Non-Current Assets for 5 consecutive years, with $1.8 million as the latest value for Q4 2024.

  • On a quarterly basis, Non-Current Assets fell 18.15% to $1.8 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.8 million, a 18.15% decrease, with the full-year FY2024 number at $1.8 million, down 18.15% from a year prior.
  • Non-Current Assets was $1.8 million for Q4 2024 at IceCure Medical, down from $2.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.2 million in Q4 2023 to a low of $650000.0 in Q4 2020.
  • A 5-year average of $1.7 million and a median of $2.0 million in 2021 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 201.38% in 2021, then dropped 18.15% in 2024.
  • IceCure Medical's Non-Current Assets stood at $650000.0 in 2020, then soared by 201.38% to $2.0 million in 2021, then increased by 5.05% to $2.1 million in 2022, then increased by 8.16% to $2.2 million in 2023, then dropped by 18.15% to $1.8 million in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Non-Current Assets are $1.8 million (Q4 2024), $2.2 million (Q4 2023), and $2.1 million (Q4 2022).